1'-Substituted-spiro[oxazolidine-5-3'-indoline]-2,2', 4-trione d

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548216, 549486, C07D49810, C07D26344, A61K 3142

Patent

active

045446628

ABSTRACT:
The invention provides novel spiro[oxazolidine-5,3'-indoline]-2,2',4-triones of formula I bearing substituted benzyl or cinnamyl on the indoline nitrogen, together with salts and non-toxic, biodegradable precursors thereof. The compounds are potent inhibitors of the enzyme aldose reductase and are useful in treating or preventing certain diabetic complications. The invention also provides pharmaceutical compositions containing, and processes for the manufacture of, the compounds of formula I and their salts and derivatives.

REFERENCES:
patent: 4200642 (1980-04-01), Schnur
patent: 4226875 (1980-10-01), Schnur
Clark-Lewis et al., J. Chem. Soc., 1965, 5551-5556.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1'-Substituted-spiro[oxazolidine-5-3'-indoline]-2,2', 4-trione d does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1'-Substituted-spiro[oxazolidine-5-3'-indoline]-2,2', 4-trione d, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1'-Substituted-spiro[oxazolidine-5-3'-indoline]-2,2', 4-trione d will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1442739

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.